Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MAP3K7 |
| Upstream (Parents) |
|---|
| (<<) DLX2 → MAP3K7 |
| (<<) GRHPR → MAP3K7 |
| (<<) INHBA → MAP3K7 |
| (<<) JHDM1D → MAP3K7 |
| (<<) PRDX6 → MAP3K7 |
| (<<) RAB22A → MAP3K7 |
| (<<) RNF11 → MAP3K7 |
| Downstream (Children) |
|---|
| MAP3K7 → CALML5 (>>) |
| MAP3K7 → CLPP (>>) |
| MAP3K7 → CSNK1A1 (>>) |
| MAP3K7 → EZR (>>) |
| MAP3K7 → HDAC4 (>>) |
| MAP3K7 → ITGB8 (>>) |
| MAP3K7 → MTMR6 (>>) |
| MAP3K7 → NUPR1 (>>) |
| MAP3K7 → PELO (>>) |
| MAP3K7 → PRKAA1 (>>) |
| MAP3K7 → RCBTB1 (>>) |
| MAP3K7 → RRP15 (>>) |
| MAP3K7 → SLC16A6 (>>) |
| MAP3K7 → SPPL2B (>>) |
| MAP3K7 → WNT5B (>>) |
